SCHEMBL7419734

SCHEMBL7419734

CC(=O)Cc1cnc2c(c1)CN(C)C(=O)N2C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 1/20 0.31
CYP11B2 P19099 1/20 0.30
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7404024 0.80 CYP11B2 (0.44) CYP11B2
SCHEMBL7421949 0.74 BRD4 (0.40)
SCHEMBL7413307 0.73 BRD4 (0.35) EGFR
SCHEMBL7412280 0.71 FGFR4 (0.34)
SCHEMBL7324315 0.69 GABRA5 (0.41) CYP11B2
SCHEMBL7416891 0.65 XIAP (0.41)
SCHEMBL7415204 0.64 HSD17B10 (0.53)
SCHEMBL8627202 0.64 ALDH1A1 (0.34) CYP11B2
SCHEMBL7439109 0.64 BRD4 (0.56)
SCHEMBL19508034 0.63 FGFR4 (0.40) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5002944-A Compounds having cardiotonic activity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-03-26 US disclosed
EP-0333727-A1 HETEROCYCLIC SUBSTITUTED BICYCLOUREAS HAVING CARDIOTONIC ACTIVITY RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1989-09-27 EP disclosed
US-4859672-A Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone RORER PHARMACEUTICAL CORPORATION (US) 1989-08-22 US disclosed
WO-1988003025-A1 HETEROCYCLIC SUBSTITUTED BICYCLOUREAS HAVING CARDIOTONIC ACTIVITY RORER INTERNATIONAL (OVERSEAS) INC. (US) 1988-05-05 WO disclosed